INSPIRE LTE study
Research payments
$2,825,820
Through program year 2025, $2,825,820 in research payments was reported against INSPIRE LTE study, across 1,214 payments, paid by Sun Pharmaceutical Industries Inc..
- Paid by
- Sun Pharmaceutical Industries Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,066,711 | 263 |
| 2024 | Research | $845,790 | 392 |
| 2023 | Research | $689,215 | 342 |
| 2022 | Research | $224,104 | 217 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Shaikh Ali Tomball, TX Named on 85 payments
- Isam Diab Middleburg Hts, OH Named on 54 payments
- Jitendra Vasandani Lubbock, TX Named on 44 payments
- Melvin Churchill Lincoln, NE Named on 41 payments
- Edmund Lacour Dothan, AL Named on 37 payments
- Robert Hozman Skokie, IL Named on 31 payments
- Robert Levin Clearwater, FL Named on 30 payments
- Steven Kimmel Tamarac, FL Named on 30 payments
- Farrukh Zaidi Port Richey, FL Named on 29 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.